Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study
Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study
批准号:
8720467
负责人:
Matthew L Warman
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2015-05-31
关键词:
AffectAgeAmericanApplications GrantsAreaBaltimoreBasic ScienceBiologicalBiologyBone DiseasesCellsClinicalClinical ResearchCollaborationsCongenital AbnormalityDevelopmentDiseaseDisease ProgressionEducational workshopEnsureEventFamilyFosteringFundingGenesGeneticGoalsGrowthHealthHealth AllianceHumanIndividualIndustryJointsJournalsKnowledgeLearningLive BirthMaintenanceMarylandMineralsOsteoporosisOutcomeParticipantPathway interactionsPatientsPatternPeer ReviewPublicationsPublishingQuality of lifeRare DiseasesReportingRequest for ApplicationsResearchResearch PersonnelScientistSkeletal systemSkeletonSocietiesSurgeonTexasTherapeuticTranslational ResearchUnderrepresented MinorityUnited StatesUnited States National Institutes of HealthUpdateWomanabstractingbonebone healthbone massdesigndisabilitydrug discoveryimprovedinsightlecturesmeetingsnovelpreventprogramspublic health relevanceskeletalsymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bone health is critical to overall health and quality of life; the skeletal system provides the body mobility, support and protection, and serves as a major reservoir for essential minerals. But not everyone enjoys good bone health. To date, nearly 500 unique rare bone diseases have been described, which in the aggregate affect 1 in 5,000 live births, and comprise 5% of all birth defects. Typically the disability caused by these diseases affects individuals throughout their lives. Currently, the vast majority of these disorder have no cure, yet studying rare bone diseases has helped elucidate biological pathways and reveal valuable targets for drug discovery that are benefitting patients with common bone diseases too. This grant application requests partial support for "Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases," a workshop being coordinated by the National Bone Health Alliance (NBHA) in partnership with the Rare Bone Disease Patient Network and with the support of the American Society for Bone and Mineral Research (ASBMR) and the United States Bone and Joint Initiative (USBJI). The specific aims of the workshop are to: 1) Convene a multi-disciplinary group of experts including researchers, clinicians, and patients with rare bone diseases to advance our understanding of skeletal biology and encourage the development of novel therapies to improve outcomes for individuals with both common and rare bone diseases; 2) Identify gaps in our knowledge regarding the biologic mechanisms underlying rare bone disorders and share effective research strategies in translational and therapeutic areas; 3) Encourage broad participation both by holding the event the day before the ASBMR 2014 Annual Meeting and providing funding for a significant number of young investigators to attend; and 4) Disseminate the results broadly by publishing the proceedings of the program in a peer-reviewed journal. The one-day workshop will be held on September 11, 2014 in Houston, Texas, the day before the ASBMR 2014 Annual Meeting, the premier gathering of academic and clinical leaders in bone and mineral research. This pairing will encourage the greatest number of scientists, clinicians, and young investigators to participate in the workshop. The workshop will include lectures by invited speakers, and multiple opportunities to initiate collaborations and encourage future research partnerships. The planning committee has been confirmed and will ensure inclusion of women, individuals with disabilities, and participants from underrepresented groups.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Mechanistic and therapeutic insights gained from studying rare skeletal diseases.
从研究罕见骨骼疾病中获得的机制和治疗见解。
DOI:
10.1016/j.bone.2015.03.016
发表时间:
2015
期刊:
Bone
影响因子:
4.1
作者:
[Tosi,LauraL, Warman,MatthewL]
通讯作者:
Warman,MatthewL
Conditional mouse models with dominant negative Osteogenesis Imperfecta
-
批准号:10646852
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2023
-
负责人:Matthew L Warman
-
依托单位:
Skeletal and non-skeletal roles for osteocalcin
-
批准号:10417887
-
项目类别:
-
资助金额:$39.81万
-
财政年份:2022
-
负责人:Matthew L Warman
-
依托单位:
Skeletal and non-skeletal roles for osteocalcin
-
批准号:10595042
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2022
-
负责人:Matthew L Warman
-
依托单位:
Neurobehavioral phenotypes of mouse models of Osteogenesis Imperfecta
-
批准号:10416072
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2021
-
负责人:Matthew L Warman
-
依托单位:
Neurobehavioral phenotypes of mouse models of Osteogenesis Imperfecta
-
批准号:10303525
-
项目类别:
-
资助金额:$19.47万
-
财政年份:2021
-
负责人:Matthew L Warman
-
依托单位:
The Efficacy of combination therapy in Osteogenesis Imperfecta
-
批准号:8900679
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2015
-
负责人:Matthew L Warman
-
依托单位:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
-
批准号:9052710
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2014
-
负责人:Matthew L Warman
-
依托单位:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
-
批准号:8830919
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2014
-
负责人:Matthew L Warman
-
依托单位:
Non-heritable genetic diseases of the skeletal system: Pathogenesis and Treatment
-
批准号:9245631
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2014
-
负责人:Matthew L Warman
-
依托单位:
Does increasing bone mass also increase bone strength in mouse models of OI?
-
批准号:8232602
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2011
-
负责人:Matthew L Warman
-
依托单位:
Does increasing bone mass also increase bone strength in mouse models of OI?
-
批准号:8334034
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2011
-
负责人:Matthew L Warman
-
依托单位:
HIP JOINT REPLACEMENT FOR IDIOPATHIC OSTEOARTHRITIS AGGREGATES IN FAMILIES
-
批准号:7600991
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2007
-
负责人:Matthew L Warman
-
依托单位:
HIP JOINT REPLACEMENT FOR IDIOPATHIC OSTEOARTHRITIS AGGREGATES IN FAMILIES
-
批准号:7420644
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2006
-
负责人:Matthew L Warman
-
依托单位:
PAMIDRONATE IN CHILDREN WITH MODERATE TO SEVERE OSTEOGENESIS IMPERFECTA
-
批准号:7202750
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2005
-
负责人:Matthew L Warman
-
依托单位:
Pamidronate in children with moderate to severe osteogenesis imperfecta
-
批准号:6974948
-
项目类别:
-
资助金额:$3.23万
-
财政年份:2004
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:7119282
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:6913515
-
项目类别:
-
资助金额:$41.32万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:6764219
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:6674568
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
Lubricin Function in Articulating Joints
-
批准号:7268803
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2003
-
负责人:Matthew L Warman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: